Pre-Filled Syringes: World Industry and Market Prospects 2014-2024

LONDON, November 14, 2013 /PRNewswire/ --

Your guide to trends and sales potential for prefillable syringe products

What are the commercial prospects for pre-filled syringes and related technologies? Visiongain's report shows you potential revenues and other trends to 2024, discussing data, opportunities and prospects.

Our new study analyses those technologies and their therapeutic applications. You will find projected sales to 2024 at overall world market, submarket, injected drug and national level.

In addition to an overall world revenue forecast for pre-filled syringe products, you will see forecasting of world-level submarkets to 2024:
• Glass pre-filled syringes
• Plastic (polymer) pre-filled syringes
• Pen injectors and Autoinjectors

Also, you receive a world unit sales forecast for those medical injection units. Discover qualitative analyses (SWOT and STEP), company profiles, R&D and commercial developments. Moreover, you will gain 60 figures, 79 tables and three interviews with authorities in the industry.

Prospects for leading countries shown to 2024

Regulatory, demographic and commercial developments worldwide will influence the market, especially fast-rising demand in emerging markets.

Our analyses show you individual revenue forecasts to 2024 for 11 national markets:
• US
• Japan
• Germany,
• France,
• UK,
• Italy
• Spain
• Brazil,
• Russia,
• India
• China

Increasing development and use of biological drugs (biologics) will increase worldwide sales of these drug delivery technologies from 2014 to 2024, our study shows.

What issues decide the future of the industry and market?

Our study lets you assess industry trends and outlooks. You find discussions of many issues and developments, including R&D:
• Cost savings and efficiencies
• Plastic disposable syringes and components
• Glass single-use syringes and related parts
• Syringe technology, needles, materials and compound stability
• Safety and convenience issues for injection devices
• Product differentiation and customisation
• Reimbursement and legislation

Our investigation gives you multi-level business research and analysis with sales forecasts. You see how that industry and market can perform from 2014 to 2024.

You will discover prospects for applications of prefillable syringe technologies

Our report also analyses applications of pre-filled drug delivery technologies - medical products. You will discover world-level revenue forecasting for several drug classes to 2024 including:
• Insulins
• Growth hormones
• Low molecular weight heparins (LMWHs)
• Vaccines
• Biosimilar and follow-on protein products

Also, how will 11 injectable drugs - including Lantus, Humalog, NovoLog, Humira and Enbrel - perform from 2014? You will find the potential revenues for these drugs to 2024.

Market Size and Growth Prospects

What does the future hold? Overall revenues from pre-filled syringes will rise from 2014 to 2024, our report forecasts. Improved drug delivery and new formulations will be vital to pharmaceutical companies, increasing demand for innovative medical injection devices.

In 2012, 2.96 billion of those syringe units sold. Pre-filled syringes form one of the fastest growing markets in healthcare.

Safety, stability, convenience and cost-effectiveness benefit unit sales and revenues. Our analyses predict strong revenue growth to 2024 for those medical devices and their applications in human therapy.

Discover profiles for leading companies

Our work profiles leading companies, assessing their technologies and products. You will see activities and outlooks for developers and producers:
• Becton, Dickinson and Company
• Gerresheimer
• SCHOTT
• Ypsomed
• MGlas (Nipro)
• Unilife
• Nuova Ompi (Stevanato Group)
• Weigao
• Roselabs Bioscience
• SHL Group
• Haselmeier
• Owen Mumford
• Datwyler
• West Pharmaceutical Services

Our work also discusses companies providing syringe filling machines and associated equipment.

How the Pre-Filled Syringes: World Industry and Market Prospects 2014-2024  report helps you

In summary, our report gives you the following knowledge:
• Revenues to 2024 for the overall world market - discover that industry's prospects, finding promising areas for investments and revenues
• Discover forecasted revenue trends of leading applications
• Find projected revenues of 11 leading therapeutic products to 2024
• Market forecasting to 2024 for the US, Japan, leading EU countries (Germany, France, the UK, Italy and Spain), and BRIC countries, India, China, Brazil and Russia
• Assess 14 leading companies, and other players, discovering activities and outlooks
• Competition and opportunities - see what affects the pre-filled syringe market, learning what shapes its future, especially prospects for sustaining and developing business
• Opinions from our survey, seeing interviews with industry authorities.

You will find quantitative and qualitative analyses with independent predictions. You receive information that only our report contains, staying informed on business intelligence.

Gain research and analysis for pre-filled syringes and related drug delivery now

Our study is for everybody needing industry and market analyses for pre-filled syringes and related technologies. You find data, trends and predictions. Please order the Pre-Filled Syringes: World Industry and Market Prospects 2014-2024 report now.

Companies Listed

AbbVie
Accu-Chek (part of Roche)
Aché
Aesica Pharmaceuticals
AI Biosciences
Albany Molecular Research Inc (AMRI)
Althea Technologies
Amega Biotech
Amgen
Animas
Antares Pharma
Aptar Pharma (part of AptarGroup)
Aptar Stelmi (part of AptarGroup)
AptarGroup
Batelle
Baxter BioPharma Solutions
Bayer
Becton, Dickinson & Co. (BD)
Berlin-Chemie (part of Menarini Group)
Bespak
Biocon
BioConnection
Biodel
Biogen Idec
Bioject Medical Technologies
Biosidus
Boehringer Ingelheim
Boehringer Ingelheim BioXcellence (part of Boehringer Ingelheim)
Bristol-Myers Squibb
Cambridge Consultants
Carl Zeiss Foundation
Catalent Pharma Solutions
Centers for Disease Control and Prevention (CDC)
China Food and Drug Administration (CFDA)
Cipla
Consort Medical
Cosmo Pharmaceuticals
Crossject
Daikyo Seiko
DALI Medical Devices
Datwyler
Disetronic Group (part of Roche)
Dong-A Pharmaceutical
Dr. Reddy's Laboratories
Drug Controller General of India (DCGI)
Duoject Medical Systems
Eisai
Elcam Medical
Eli Lilly
Emisphere
European Medicines Agency (EMA)
FDA Office of Device Evaluation [US]
Ferring Pharmaceuticals
Future Injection Technologies (FIT)
Gan & Lee Pharmaceuticals
GAVI Alliance
Genentech (part of Roche)
GeneScience Pharmaceuticals (GenSci)
Gerresheimer
GSK
Haselmeier
Haselmeier Inc. (part of Haselmeier)
Hospira
Hospira One2One (part of Hospira)
Hyaluron Contract Manufacturing (HCM, part of AMRI)
Incepta Pharmaceuticals
Insulet
J&J
Jabil Circuit
Janssen Biotech (part of J&J)
Johns Hopkins University
LG Life Sciences
Marvel Life Sciences
Massachusetts Institute of Technology (MIT)
Medimop Medical Projects (part of West)
Medtronic
Merck & Co.
Merck Serono (part of Merck KGaA)
MG Sterile Products (part of Nipro)
MGlas (part of Nipro)
Ministry of Health, Labor and Welfare (MHLW) [Japan]
Ministry of Labour and Employment [Brazil]
Mitsubishi Tanabe Pharma
National Health Service (NHS) [UK]
Nektar Therapeutics
Nipro
Novartis
Novo Nordisk
Nuova Ompi (part of Stevanato Group)
Nypro (part of Jabil Circuit)
Occupational Safety and Health Administration (OSHA) [US]
Optrel (part of Stevanato Group)
Oval Medical
Owen Mumford
PA Consulting Group
PATH
Pfizer
PharmaJet
Pharmstandard
Phillips Medisize
Plastef Investissements
Polfa-Tarchomin
Primequal
Revolutions Medical
Rexam
Roche
Roselabs
Roselabs Bioscience (part of Roselabs)
ROVI CM
Safety Syringes (part of BD)
Sandoz (part of Novartis)
Sanofi
Sanofi Pasteur
Savient Pharmaceuticals
Schering-Plough (part of Merck & Co.)
Schott
Schott Kaisha
Schott Xinkang Pharmaceutical Packaging
SciGen
Shanghai Celgen Bio-Pharmaceutical
Shanghai CP Guojian Pharmaceutical
SHL Group
Spami (part of Stevanato Group)
Specialty Coating Systems (SCS)
Square Pharmaceuticals
Stevanato Group
Swedish Orphan Biovitrum (Sobi)
Taisei Kako
Terumo
Teva Pharmaceutical Industries
The Medical House (part of Bespak)
tip-top
Tonghua Dongbao Pharmaceutical
UCB
UNICEF
Unilife
University of Virginia
US Agency for International Development
US Food and Drug Administration (FDA)
Vetter Pharma
Weigao Group
West Pharmaceutical India Packaging Private (part of West)
West Pharmaceutical Services
Wockhardt
World Health Organization (WHO)
Wyeth (part of Pfizer)
Ypsomed
Zeon Corporation

To request an exec summary of this report please email Sara Peerun at sara.peerun@visiongainglobal.com

Tel : +44(0)20-7336-6100

Or click on http://www.visiongain.com/Report/1149/Pre-Filled-Syringes-World-Industry-and-Market-Prospects-2014-2024